Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation

PLoS Pathogens

Volumn 11, Issue 6, 2015, Pages

  Sei, Janet J ^a   Haskett, Scott ^b   Kaminsky, Lauren W ^a   Lin, Eugene ^a   Truckenmiller, Mary E ^a   Bellone, Clifford J ^b   Buller, R Mark ^b   Norbury, Christopher C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TOLL LIKE RECEPTOR AGONIST; VIRUS PROTEIN; VIRUS VACCINE; HLA ANTIGEN CLASS 1; PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG DESIGN; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; LYMPHOID CELL; MACROPHAGE; MOUSE; MOUSEPOX; NONHUMAN; SPLEEN CELL; ANIMAL; C57BL MOUSE; CROSS PRESENTATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHENOTYPE; TRANSGENIC MOUSE;

ECTROMELIA VIRUS; MUS; POXVIRIDAE;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; PHENOTYPE;

EID: 84936757860     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004941     Document Type: Article

References (39)

1. Belz GT, Smith CM, Eichner D, Shortman K, Karupiah G, Carbone FR, et al. Conventional CD8alpha(+) dendritic cells are generally involved in priming CTL immunity to viruses. J Immunol. 2004;172(4):1996–2000. 14764661
2. den Haan JM, Lehar SM, Bevan MJ, CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med. 2000;192(12):1685–96. 11120766
3. Pooley JL, Heath WR, Shortman K, Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol. 2001;166(9):5327–30. 11313367
4. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science. 2003;301(5641):1925–8. 14512632
5. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808):107–11. 17204652
6. Lee HK, Zamora M, Linehan MM, Iijima N, Gonzalez D, Haberman A, et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med. 2009;206(2):359–70. doi: 10.1084/jem.20080601 19153243
7. Kastenmuller W, Kastenmuller K, Kurts C, Seder RA, Dendritic cell-targeted vaccines—hope or hype? Nat Rev Immunol. 2014;14(10):705–11. doi: 10.1038/nri3727 25190285
8. Freer G, Matteucci D, Influence of dendritic cells on viral pathogenicity. PLoS Pathog. 2009;5(7):e1000384. doi: 10.1371/journal.ppat.1000384 19649323
9. Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ, Viral evasion of T cell immunity: ancient mechanisms offering new applications. Curr Opin Immunol. 2011;23(1):96–103. doi: 10.1016/j.coi.2010.11.005 21146386
10. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol. 1999;163(12):6762–8. 10586075
11. Welten SP, Melief CJ, Arens R, The distinct role of T cell costimulation in antiviral immunity. Curr Opin Virol. 2013;3(4):475–82. doi: 10.1016/j.coviro.2013.06.012 23850168
12. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM, Induction of natural killer cell responses by ectromelia virus controls infection. J Virol. 2007;81(8):4070–9. 17287257
13. Fischer MA, Tscharke DC, Donohue KB, Truckenmiller ME, Norbury CC, Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. J Gen Virol. 2007;88(Pt 9):2378–86.
14. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN, Localization, quantitation, and in situ detection of specific peptide- MHC class I complexes using a monoclonal antibody. Immunity. 1997;6(6):715–26. 9208844
15. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR, T cell receptor antagonist peptides induce positive selection. Cell. 1994;76(1):17–27. 8287475
16. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW, Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol. 2002;3(3):265–71. 11828323
17. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, Mays JW, et al. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med. 2011;208(12):2511–24. doi: 10.1084/jem.20102545 22042976
18. Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, Young L, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol. 2006;7(2):165–72. 16415871
19. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A, Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 1999;189(5):821–9. 10049946
20. Wong YC, Smith SA, Tscharke DC, Systemic toll-like receptor ligation and selective killing of dendritic cell subsets fail to dissect priming pathways for anti-vaccinia virus CD8(+) T cells. J Virol. 2013;87(22):11978–86. doi: 10.1128/JVI.01835-13 23986587
21. Li J, Schuler-Thurner B, Schuler G, Huber C, Seliger B, Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. Int Immunol. 2001;13(12):1515–23. 11717192
22. Lelouard H, Gatti E, Cappello F, Gresser O, Camosseto V, Pierre P, Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature. 2002;417(6885):177–82. 12000969
23. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008;322(5904):1097–100. doi: 10.1126/science.1164206 19008445
24. Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA, Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high antigen induction of apoptosis of effector CTL. J Exp Med. 1996;184:485–92. 8760802
25. Restifo NP, Bacik I, Irvine KR, Yewdell JW, McCabe BJ, Anderson RW, et al. Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol. 1995;154(9):4414–22. 7722298
26. Bullock TN, Mullins DW, Engelhard VH, Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol. 2003;170(4):1822–9. 12574347
27. Wherry EJ, Puorro KA, Porgador A, Eisenlohr LC, The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol. 1999;163(7):3735–45. 10490969
28. Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ, Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog. 2010;6(2):e1000768. doi: 10.1371/journal.ppat.1000768 20169189
29. Sevilla N, Kunz S, McGavern D, Oldstone MB, Infection of dendritic cells by lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol. 2003;276:125–44. 12797446
30. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol. 2012;13(9):888–99. doi: 10.1038/ni.2370 22797772
31. Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, et al. Peptide Diffusion, Protection, and Degradation in Nuclear and Cytoplasmic Compartments before Antigen Presentation by MHC Class I. Immunity. 2003;18(1):97–108. 12530979
32. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR, Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000;404:770–4. 10783891
33. Khan S, van den Broek M, Schwarz K, de Giuli R, Diener PA, Groettrup M, Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J Immunol. 2001;167(12):6859–68. 11739503
34. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Henrickson SE, et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature. 2010;465(7301):1079–83. doi: 10.1038/nature09118 20577213
35. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488–95. P doi: 10.1038/ni.1724 19349986
36. Beauchamp NM, Busick RY, Alexander-Miller MA, Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol. 2010;84(19):10191–9. doi: 10.1128/JVI.00892-10 20660207
37. Ruiz-Arguello MB, Smith VP, Campanella GS, Baleux F, Arenzana-Seisdedos F, Luster AD, et al. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol. 2008 Jan;82(2):917–26. 18003726
38. Koller BH, Marrack P, Kappler JW, Smithies O, Normal development of mice deficient in β2-microglobulin, MHC class I proteins, and CD8+ T cells. Science. 1990;248(4960):1227–30. 2112266
39. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S, TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell. 1992;71(7):1205–14. 1473153